Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Optimization of Music Compression (OMC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02373228
Recruitment Status : Completed
First Posted : February 26, 2015
Last Update Posted : October 20, 2015
Sponsor:
Information provided by (Responsible Party):
Phonak AG, Switzerland

Brief Summary:
Hearing impaired persons suffer from inferior music perception with and without hearing aids. Hearing aids, however, are primarily designed to improve speech intelligibility not music enjoyment. This study investigates the potential benefit of signal processing strategies that are optimized for music. The purpose of this study is to improve music compression for hearing impaired people.

Condition or disease Intervention/treatment Phase
Hearing Loss Other: Audio signal processing (applied offline before playback) Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 20 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Official Title: Optimization of Music Compression for People With Hearing Impairment
Study Start Date : January 2015
Actual Primary Completion Date : July 2015
Actual Study Completion Date : July 2015

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Compressive signal processing algorithm
Participants compare music signals with preprocessing to the same music signals without compressive preprocessing.
Other: Audio signal processing (applied offline before playback)



Primary Outcome Measures :
  1. Benefit of signal processing for music perception [ Time Frame: 3 months ]
    Participants rate the enjoyment of music in 4 separate sessions, spread over an anticipated time frame of 3 months.


Secondary Outcome Measures :
  1. Performance in music discrimination tests [ Time Frame: 3 months ]
    Participants perform an adaptive music discrimination test in which their discrimination thresholds are measured.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 99 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Female and male adults between 18 and 99 years
  • German-speaking
  • Symmetric, mild to severe, ski-slope hearing loss
  • Binaural hearing aid user without frequency lowering
  • Informed Consent as documented by signature

Exclusion Criteria:

  • Have taken part in a study at Phonak within 4 months prior to the first session
  • People with mental-health problems
  • People whose audiogram is older than 12 months and it is not possible make a reliable measurement
  • Very limited motor activity or mobility

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02373228


Locations
Layout table for location information
Switzerland
Phonak AG
Staefa, Zürich, Switzerland, 8005
Sponsors and Collaborators
Phonak AG, Switzerland
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Phonak AG, Switzerland
ClinicalTrials.gov Identifier: NCT02373228    
Other Study ID Numbers: KEK-ZH 2014-0520
First Posted: February 26, 2015    Key Record Dates
Last Update Posted: October 20, 2015
Last Verified: January 2015
Additional relevant MeSH terms:
Layout table for MeSH terms
Hearing Loss
Hearing Disorders
Ear Diseases
Otorhinolaryngologic Diseases
Sensation Disorders
Neurologic Manifestations
Nervous System Diseases